Skip to main content
Atul Limited. logo

Atul Limited. — Investor Relations & Filings

Ticker · ATUL ISIN · INE100A01010 LEI · 335800RE4LWLLDL2OQ62 BSE.NS Manufacturing
Open in API
Filings indexed 1,342 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country IN India
Listing BSE.NS ATUL

About Atul Limited.

https://www.atul.co.in/

Atul Limited is an integrated chemical company that manufactures a diverse range of products across several business segments, including Life Science Chemicals and Performance and Other Chemicals. The company's portfolio encompasses aromatics, bulk chemicals, colors, crop protection agents, polymers, and pharmaceutical intermediates. These products serve a broad spectrum of applications in sectors such as agriculture, construction, textiles, automotive, and healthcare. The organization focuses on complex chemical synthesis and large-scale production, leveraging research and development to optimize manufacturing processes. By maintaining a comprehensive supply chain and diverse manufacturing capabilities, the company provides essential raw materials and specialized formulations to a global customer base while adhering to standards of operational efficiency and environmental responsibility.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings
2026-06-02 English
As attached
Regulatory Filings
2026-06-02 English
Letter attached
Regulatory Filings Classification · 88% confidence The document is a Secretarial Compliance Report issued by a Practicing Company Secretary under SEBI LODR regulations. It is a compliance certificate/attestation (an officer certification), not a full financial or annual report. It confirms regulatory compliance and is certified by the company secretary. According to the CERTIFICATION RULE this should be classified as a Regulatory Filing (RNS).
2026-05-15 English
Product launch
Regulatory Filings Classification · 75% confidence The document is a regulatory disclosure to the BSE and NSE under SEBI LODR Regulation 30, providing an advance copy of a press release on product launches. It is not a financial report, earnings release, management change, dividend notice, or other specialized category. It is a general regulatory announcement/filing required by the stock exchanges. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-13 English
Letter attached
Regulatory Filings Classification · 85% confidence The document is an advance copy of a press release notifying stock exchanges of a new product launch under SEBI Listing Regulations (Regulation 30). It contains a corporate disclosure rather than substantive financial data, management commentary, or a formal report. This falls under general regulatory announcements or compliance filings. Therefore, it is best classified as a Regulatory Filing (RNS).
2026-05-13 English
Letter attached
Interim / Quarterly Report Classification · 78% confidence The document is a stock‐exchange filing under SEBI LODR Regulations detailing the Board Meeting outcome, including full financial results (audited standalone and consolidated) for the quarter and year ended March 31, 2026, with detailed income statement and balance sheet numbers. It is not a full annual report (10-K), nor merely a press‐style earnings summary; it contains substantive financial statements for a quarterly/periodic period and is filed as the mandatory quarterly/annual results announcement. This matches the “Interim / Quarterly Report” (IR) category. FY 2026
2026-04-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.